Find Research Projects

Search results

• ELII: Capturing Global Biodiversity of Pathogens by Whole Genome Sequencing Guidelines for Integrating Safety and Cost-Effectiveness into Resurfacing, Restoration, and Rehabilitation Projects

  Weaver, S.

  12/16/13 → 4/16/16

  Project: Other project

• Protocol No. 771-0010: "A PMA Post-Approval Study to Evaluate the Long-Term Safety and Effectiveness of the Ovation/Ovation Prime Abdominal Stent Graft System"

  Silva, M.

  12/18/13 → 12/17/20

  Project: Other project

• Protocol No. 771-0010: "A PMA Post-Approval Study to Evaluate the Long-Term Safety and Effectiveness of the Ovation/Ovation Prime Abdominal Stent Graft System"

  Silva, M.

  TriVascular Inc

  12/18/13 → 12/17/20

  Project: Other project

• Protocol No. 771-0010: "A PMA Post-Approval Study to Evaluate the Long-Term Safety and Effectiveness of the Ovation/Ovation Prime Abdominal Stent Graft System"

  Silva, M.

  12/18/13 → 12/17/20

  Project: Other project

• Protocol #CL0018-01: "A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis"

  Silva, M.

  12/18/13 → 12/17/20

  Project: Other project

• Protocol #CL0018-01: "A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis"

  Silva, M.

  Lutonix Inc

  12/18/13 → 12/17/20

  Project: Other project

• Protocol #CL0018-01: "A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis"

  Silva, M.

  12/18/13 → 12/17/15

  Project: Other project

• The Contribution of Delta Rays to the Chromosome Aberration Dose Response in Human Cells Irradiated with HZE Particles of Different Energy but the Same LET

  Loucas, B.

  12/20/13 → 5/19/18

  Project: Other project

• The Contribution of Delta Rays to the Chromosome Aberration Dose Response in Human Cells Irradiated with HZE Particles of Different Energy but the Same LET

  Loucas, B.

  12/20/13 → 5/19/18

  Project: Other project

• Grant #71009: Oxandrolone and Propranolol Recovery in the Severely Burned

  Suman, O.

  1/1/14 → 12/31/16

  Project: Other project

• ELII: Outpatient Ambulatory Medical Care - Ryan White Part B (supplement)

  Keiser, P.

  Resource Group

  1/1/14 → 8/31/14

  Project: Other project

• ELII: Outpatient Ambulatory Medical Care - Ryan White Part B (supplement)  

  Keiser, P.

  1/1/14 → 8/31/14

  Project: Other project

• Development of a West Nile Virus Vaccine Using a Novel Nanofiber Platform

  Beasley, D.

  1/1/14 → 6/30/17

  Project: Other project

• Development of a West Nile Virus Vaccine Using a Novel Nanofiber Platform

  Beasley, D.

  1/1/14 → 12/31/16

  Project: Other project

• Development of a West Nile Virus Vaccine Using a Novel Nanofiber Platform

  Beasley, D.

  Robert J Kleberg and Helen C. Kleberg Foundation

  1/1/14 → 6/30/17

  Project: Other project

• ELII: Outpatient Ambulatory Medical Care - Ryan White Part B (supplement)

  Keiser, P.

  1/1/14 → 8/31/14

  Project: Other project

• ELII: Outpatient Ambulatory Medical Care - Ryan White Part B (supplement)  

  Keiser, P.

  Resource Group

  1/1/14 → 8/31/14

  Project: Other project

• ELII: Outpatient Ambulatory Medical Care - Ryan White Part B (supplement)

  Keiser, P.

  1/1/14 → 8/31/14

  Project: Other project

• Grant #71009: Oxandrolone and Propranolol Recovery in the Severely Burned

  Suman, O.

  Shriners Hospitals for Children - Texas

  1/1/14 → 12/31/16

  Project: Other project

• Grant #71009: Oxandrolone and Propranolol Recovery in the Severely Burned

  Suman, O.

  1/1/14 → 12/31/15

  Project: Other project

• ELII: Outpatient Ambulatory Medical Care - Ryan White Part B (supplement)

  Keiser, P.

  1/1/14 → 8/31/14

  Project: Other project

• Tolerogenic dendritic cells in antiphospholipid syndrome

  Gonzalez, E.

  1/14/14 → 11/30/14

  Project: Other project

• A retrospective survey of preterm patients with preeclampsia who were hospitalized at potential clinical trial sites over the previous two years to establish feasibility for the PRESERVE-1 study.

  Saade, G.

  1/17/14 → 1/16/16

  Project: Other project

• A retrospective survey of preterm patients with preeclampsia who were hospitalized at potential clinical trial sites over the previous two years to establish feasibility for the PRESERVE-1 study.

  Saade, G.

  1/17/14 → 1/16/16

  Project: Other project

• A retrospective survey of preterm patients with preeclampsia who were hospitalized at potential clinical trial sites over the previous two years to establish feasibility for the PRESERVE-1 study.

  Saade, G.

  1/17/14 → 1/16/16

  Project: Other project

• Robert E. Shope International Fellowship - Gillian Eastwood

  Weaver, S.

  American Society of Tropical Medicine an

  2/1/14 → 1/31/15

  Project: Other project

• High Affinity Modulators of Delta Fos B. A Protein Involved in Resilence

  Rudenko, G.

  Brain and Behavior Research Foundation

  2/1/14 → 9/14/16

  Project: Other project

• ELII Restricted Ike

  Moore, M.

  2/1/14 → 1/31/16

  Project: Other project

• Robert E. Shope International Fellowship - Gillian Eastwood

  Weaver, S.

  2/1/14 → 1/31/15

  Project: Other project

• Robert E. Shope International Fellowship - Gillian Eastwood

  Weaver, S.

  2/1/14 → 1/31/15

  Project: Other project

• High Affinity Modulators of Delta Fos B. A Protein Involved in Resilence

  Rudenko, G.

  2/1/14 → 9/14/16

  Project: Other project

• ELII Restricted Ike

  Moore, M.

  2/1/14 → 1/31/15

  Project: Other project

• An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestationsof Antiphospholipid Syndrome

  Gonzalez, E.

  Quintiles, Inc.

  2/4/14 → 11/17/17

  Project: Other project

• An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestationsof Antiphospholipid Syndrome

  Gonzalez, E.

  2/4/14 → 11/17/17

  Project: Other project

• An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestationsof Antiphospholipid Syndrome

  Gonzalez, E.

  2/4/14 → 11/17/17

  Project: Other project

• Laboratory Services Portion of Protocol Study ALXN1007-APS-201

  Gonzalez, E.

  2/6/14 → 11/17/17

  Project: Other project

• Laboratory Services Portion of Protocol Study ALXN1007-APS-201

  Gonzalez, E.

  Quintiles, Inc.

  2/6/14 → 11/17/17

  Project: Other project

• Laboratory Services Portion of Protocol Study ALXN1007-APS-201

  Gonzalez, E.

  2/6/14 → 11/17/17

  Project: Other project

• V503-010-0007: A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, administered in Preadolescents and Adolescents (9 to 14 yea

  Rupp, R.

  2/7/14 → 2/6/16

  Project: Other project

• V503-010-0007: A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, administered in Preadolescents and Adolescents (9 to 14 yea

  Rupp, R.

  2/7/14 → 2/6/19

  Project: Other project

• V503-010-0007: A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, administered in Preadolescents and Adolescents (9 to 14 yea

  Rupp, R.

  Merck Sharp & Dohme Corporation

  2/7/14 → 2/6/19

  Project: Other project

• ELII: Advanced Eye Imaging Project - FA8650-14-D-6519 (TASC, INC.)

  Motamedi, M.

  2/10/14 → 6/30/16

  Project: Other project

• ELII: Advanced Eye Imaging Project - FA8650-14-D-6519 (TASC, INC.)

  Motamedi, M.

  2/10/14 → 6/30/16

  Project: Other project

• ELII: Advanced Eye Imaging Project - FA8650-14-D-6519 (TASC, INC.)

  Motamedi, M.

  TASC, Inc.

  2/10/14 → 6/30/16

  Project: Other project

• ELII: Novel vaccines directed against Burkholderia pseudomallei and Burkholderia mallei

  Torres, A.

  University of South Alabama

  2/18/14 → 5/31/17

  Project: Other project

• ELII: Novel vaccines directed against Burkholderia pseudomallei and Burkholderia mallei

  Torres, A.

  University of South Alabama

  2/18/14 → 5/31/17

  Project: Other project

• ELII: Novel vaccines directed against Burkholderia pseudomallei and Burkholderia mallei

  Torres, A.

  2/18/14 → 5/31/17

  Project: Other project

• ELII: Multi-pathogen antiviral medical countermeasure deploying FDA approved drug against Orthopoxvirus

  Paessler, S.

  2/24/14 → 10/31/15

  Project: Other project

• ELII: Multi-pathogen antiviral medical countermeasure deploying FDA approved drug against Orthopoxvirus

  Paessler, S.

  Inhibikase Therapeutics Inc.

  2/24/14 → 10/31/15

  Project: Other project

• ELII: Molecular Mechanisms of The Synaptic Organizer Alpha-Neurexin

  Rudenko, G.

  National Inst of Mental Health

  2/28/14 → 5/31/18

  Project: Other project